Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice

OBJECTIVES: High fructose feeding changes fibroblast growth factor 21 (FGF21) regulation. Lactobacillus rhamnosus GG (LGG) supplementation reduces fructose-induced non-alcoholic fatty liver disease (NAFLD). The aim of this study was to determine the role of FGF21 and underlying mechanisms in the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Cuiqing, Liu, Liming, Liu, Qi, Li, Fengyuan, Zhang, Lihua, Zhu, Fenxia, Shao, Tuo, Barve, Shirish, Chen, Yiping, Li, Xiaokun, McClain, Craig J., Feng, Wenke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812038/
https://www.ncbi.nlm.nih.gov/pubmed/31668386
http://dx.doi.org/10.1016/j.molmet.2019.08.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812038/
https://www.ncbi.nlm.nih.gov/pubmed/31668386
http://dx.doi.org/10.1016/j.molmet.2019.08.020

Ejemplares similares